Chapter 159: Insurance Against the King of Viruses
The laboratory self-destruct sequence ran its countdown.
David stood in the high-temperature sterilization chamber and waited for the cycle to complete.
The BSL-4 protective suit's thermal layer was rated for 300 degrees Celsius. The sterilization chamber operated at 280. He stood inside it with the focused patience of someone performing a necessary procedure correctly rather than hurrying through it.
When the cycle completed, he ran the secondary decontamination protocol. Then the tertiary. The three-stage sequence was what the laboratory's design required, and the design had been built by people who understood what they were designing for. He followed it completely.
He emerged from the final stage and checked the thermal-resistant sealed container in his hand — rated for 1000-degree exposure, the specific grade used for extreme-environment viral containment transport. He placed it and the protective suit in the base incinerator. The incinerator's maximum temperature was 900 degrees Celsius. He ran it at full capacity and waited.
While the incinerator ran, he checked himself systematically — the specific self-assessment protocol for potential exposure events, working through the symptom checklist that the onset timeline of the modified virus required. The modification Amherst had described produced initial symptoms within ten minutes of exposure. He was at seventeen minutes from the last possible exposure point.
No symptoms.
The procedure had been clean.
He retrieved the sealed container when the incinerator completed its cycle — scalding through the heat-resistant gloves, but intact and confirmed sterile on the exterior. Inside the container, in a sealed secondary environment, was a sample quantity of what Amherst had created.
He carried it out of the sterilization area.
The base's general space, after the high-temperature alert and the laboratory countdown, had the specific quality of a place that had been through something and was processing it.
Harold was at the primary workstation.
He looked up when David came in, and his eyes went to the sealed container, and something in his posture shifted in the specific way that Harold's posture shifted when he had identified a variable he was not comfortable with.
"Amherst," Harold said.
"Gone," David said. "The laboratory is gone. Everything that was in it is gone." He paused. "Except this."
Harold looked at the container.
"What is it?" Harold said.
David set the container down on the secondary table — away from the workstations, in the specific location that communicated: this is contained, this is not going anywhere, this is under control.
"Amherst's final project," David said. "A heat-stable composite viral agent — four Level 4 pathogens, combined through the gene editing methodology he'd been developing since before the Illuminati Society recruited him. Transmission through any vector. Onset at ten minutes. Fatal at approximately forty. The only effective inactivation method is heat above 60 degrees Celsius." He paused. "He called it the King of Viruses. The name is not inaccurate."
Harold stared at him.
"David," Harold said. His voice was very even. That was the most significant thing about it.
"I know," David said.
"You brought that into this base," Harold said.
"In a triple-sealed, incinerator-treated, 1000-degree-rated container," David said. "Yes." He paused. "Harold. The Elder's location is the Moroccan Sahara. John is going to need to reach that location. The Elder is not going to be alone. The standard approach — the approach John used before — requires John to arrive at the point of near-death before the Elder's network allows contact. In that condition, John cannot physically address a protected target." He paused. "The Elder cannot be reached by conventional means. What's in that container is a precision delivery mechanism — a single-use, targeted agent that can be deployed in a confined geographic area and that degrades beyond the target zone because the ambient temperature at the outer desert perimeter exceeds the virus's viable range." He paused. "It's surgical. Not mass deployment."
"It is a weapon of mass destruction in a container," Harold said.
"Yes," David said. "And the surgical application requires a delivery mechanism and a self-limiting parameter that I haven't solved yet." He looked at Harold directly. "Which is why I need help."
Harold was quiet for a long moment.
He looked at the container.
He looked at the Machine's terminal, which was running its continuous assessment with the focused attention of something that was aware of everything in the room and was forming its own assessment of it.
"The Machine," Harold said.
"Yes," David said.
Harold turned to the terminal.
The Machine produced: I know what's in the container. I've been following the laboratory sequence through the camera network. I want to ask a question before we proceed.
"Ask," David said.
The delivery mechanism problem — the containment of the agent to the target geographic area — requires either a physical delivery system or a biological self-limiting parameter. The physical delivery system requires someone to be present at the delivery point and to be able to exit the area before the agent activates. The biological self-limiting parameter requires the agent to be modified to degrade at the perimeter temperature without human intervention. Which approach are you pursuing?
"The biological parameter," David said. "The physical delivery approach requires John to be at the delivery point in a condition that doesn't allow for safe exit. The biological parameter allows the agent to be deployed in advance of John's arrival, with John present during the active window and clearing the area before the perimeter degradation threshold."
That modification requires a virologist capable of working with the composite genome at the level Amherst was working. A pause. Amherst is gone.
"There are two researchers at the CDC's emergency response division who have the relevant expertise," David said. "Dr. Nancy Jaax and Dr. C.J. Peters. Their work on filovirus containment — specifically the Reston Ebola situation in 1989 — involved exactly the class of environmental parameter modification I'm describing. They understand how to engineer environmental degradation thresholds into viral agents because they spent three years understanding how natural viruses fail to degrade in specific environmental conditions." He paused. "The inverse of that knowledge is what I need."
Nancy Jaax is currently consulting with USAMRIID on the poliovirus emergency response, the Machine produced. Peters is at the University of Texas Medical Branch. Both are within reachable distance.
"I need to talk to them," David said. "Not through official channels. Directly."
I can locate them precisely. A pause. David. I want to note that what you're proposing — bringing CDC researchers into contact with the agent in that container — creates an exposure risk that has to be managed at the highest possible standard.
"I know," David said. "The conversation happens without the container present. They work from the agent's genome sequence only — Root can extract the full sequence from the contained sample through spectral analysis without opening the containment. They get the sequence data. They don't get the physical agent."
That's the correct approach, the Machine said. I'll locate them.
Harold was looking at the terminal with the expression of someone who had followed an argument to its conclusion and found the conclusion genuinely uncomfortable and also correct.
"This is the plan you've had since before Amherst built it," Harold said.
"The plan required the agent to exist first," David said. "I needed Amherst to build it before I could plan around it."
"You let him build a virus capable of human extinction," Harold said.
"I let him build a virus capable of functioning as a precision instrument under specific controlled conditions," David said. "In a sealed environment with a containment protocol I designed. With a self-destruct sequence that eliminated the laboratory and all materials except the contained sample." He paused. "The difference between a precision instrument and a weapon of mass destruction is the delivery system and the use case. What's in that container is a sample quantity in triple containment. It's not a weapon yet. It becomes one or it becomes an instrument depending on what we do next."
Harold looked at him.
"You should have told us," Harold said. It was not an accusation. It was a statement of principle delivered with the quiet force of someone who means it.
"Yes," David said. "I should have." He paused. "I didn't because I wasn't certain it would work. Amherst might not have produced a viable agent. The containment might have failed. The self-destruct might have been insufficient." He paused. "I didn't want to create the weight of knowing about this before I knew whether this existed." He looked at Harold directly. "That was the wrong call. You should have known."
Harold was quiet.
"Yes," he said finally. "I should have." He paused. "Don't do it again."
"I won't," David said.
Harold turned to the terminal and began working.
Root was in the corridor when David came out.
She had the specific quality she carried when she had been listening to a conversation through the base's internal audio and was organizing her response to it.
"The CDC," she said.
"Yes," David said.
"I've already run the location on Jaax and Peters," she said. "Jaax is at the CDC's emergency coordination center in lower Manhattan — she's been there since the poliovirus declaration. Peters is in Galveston." She paused. "Peters is too far for the timeline. Jaax is thirty minutes away."
"Jaax it is," David said.
"The sequence extraction," Root said. "From the contained sample. I can run it through the base spectrometer using a remote probe that doesn't require opening the containment layer. It'll take forty minutes for a complete sequence read." She paused. "I'll have the data package ready before you reach Jaax."
"Good," David said.
Root looked at the sealed container, which was visible through the workstation doorway.
"Amherst," she said.
"Gone," David said.
Root looked at him.
"It was his choice," David said. "He understood what he was doing."
Root was quiet for a moment.
"The King of Viruses," she said. She'd apparently been listening to the full conversation.
"Yes," David said.
"And you're going to use it to kill the Elder," Root said.
"If the modification works," David said. "If Jaax can engineer the thermal degradation parameter. If the delivery can be coordinated with John's approach. If the Elder's perimeter security doesn't detect the deployment in advance." He paused. "There are a lot of ifs."
"There always are," Root said.
She produced a car key from her jacket pocket and pressed it. In the tunnel's darkness, forty feet away, two headlights flashed once and went dark.
David looked at the car.
He looked at Root.
"You parked a vehicle in the tunnel," he said.
"Several days ago," Root said. "When it became clear that the operational tempo was going to require rapid exit capability without using the street entrance." She paused. "Harold knew."
"Harold knows everything," David said.
"Almost everything," Root said.
They walked toward the car.
The base's common space had the specific atmosphere that followed difficult operational conclusions — not defeat, not celebration, but the specific in-between of people who have done something hard and are sitting with the result of it.
Reese was on the platform edge with the unused syringe.
He'd come back with it untouched. He'd looked at the syringe for a long time after coming back from wherever he'd been walking, and then he'd put it down on the platform beside him with the careful deliberateness of someone setting down something that has weight.
Frank was in the equipment room. The sounds from there suggested he was doing something physical with something metal, which was Frank's processing methodology.
McCall was reading.
Castle was at the secondary terminal, looking at the Wednesday tactical picture — the Fisk security rotation, the coverage gap, the institutional backing complication the Machine had identified.
Harold came out of the workstation.
He stood on the platform and looked at the assembled people with the specific posture of someone who has something to say and is choosing how to say it.
"I want to tell you something," Harold said.
The room's attention came to him.
"The Samaritan's correction algorithm — what it was going to do when it went online," Harold said. "The Machine ran the projection before the blackout. The projection calculated the number of people who would have died in the first correction cycle." He paused. "One hundred and twenty thousand people. That's what the correction algorithm would have produced in its first operational phase." He paused. "We stopped it."
The room was quiet.
"One hundred and twenty thousand," Harold said. "That's the number. I want you to know the number because I think we've been doing this work without knowing the weight of what we've been doing." He paused. "The children in New York State — we couldn't save them. That's real and it's not going away and it matters." He paused. "And we saved a hundred and twenty thousand people from a system that was going to treat them as inefficiencies to be corrected. That's also real." He paused. "Both things are true simultaneously. I want you to hold both."
Reese looked at the platform floor.
Frank, visible through the equipment room doorway, had stopped whatever he was doing.
Castle looked up from the terminal.
McCall closed his book.
"The High Table isn't done," Harold said. "The Illuminati Society isn't done. What happened to the children of New York State is the kind of thing that happens when the High Table is operational and unchallenged. We are the challenge. We are not sufficient yet — I want to be honest about that. We are not enough people and we do not have enough resources and we cannot do everything that needs to be done." He paused. "But we are the challenge. And challenges grow." He looked at the room steadily. "Rest when you can. The next phase starts tomorrow."
He went back to the workstation.
The room was quiet for a moment.
Then Frank said: "Anyone want to come lift something heavy and not talk about anything for a while?"
Reese stood up.
McCall stood up.
Castle considered for a moment, then stood up.
Frank looked at them and produced an expression that was close to satisfied.
They went to the equipment room.
The drive to lower Manhattan took twenty-eight minutes.
Root drove. David looked at the sequence data she'd extracted from the contained sample and sent to his phone — the full genomic read, the specific parameters of the composite modification, the heat stability architecture Amherst had incorporated from the extremophile research he'd been pursuing since before the Illuminati Society.
He read it carefully.
He thought about what he was going to ask Dr. Jaax to do, and how he was going to explain the context, and how much of the context was necessary for the request.
He thought about Nancy Jaax — her record, her specific professional history, the 1989 Reston situation that had put her name in the permanent literature of viral outbreak management. She had spent her career understanding how dangerous pathogens behaved in real environments and how to contain them. She had spent it looking at the gap between what viruses could theoretically do and what they actually did in controlled and uncontrolled conditions.
He thought she was the right person.
"She's not going to like this," Root said.
"No," David said.
"She's going to ask questions I can't answer on your behalf," Root said.
"I know," David said.
"Are you going to tell her the truth?" Root said.
David looked at the sequence data.
"Enough of it," he said.
Root drove.
The city passed on both sides.
The Machine's relay message arrived at 7:42 AM:
The Georgetown murine model results are complete. The vaccine candidate produces appropriate immune response in 96% of test subjects with no adverse events across the full dose range tested. House says "send it." He says to tell you that Amherst's formulation choices were unconventional in three places and in all three places the unconventional choice was better than the standard approach. He says "that is annoying but true."
The CDC distribution network is beginning production scale-up. The antiviral is already in distribution. The vaccine candidate will be in emergency production within six hours.
The acute pediatric cases — the ones who were past the antiviral window — the vaccine candidate addresses the progression from their current state. It does not reverse existing damage. But it stops the forward progression. The neurological deterioration halts.
The number of children who will not lose further function because of what was done in the last twelve hours is significant.
David read the message.
He read it twice.
He thought about Amherst making a genuine vaccine in the base's Level 4 laboratory at 4 AM, working with the focused precision of someone who was in their element, describing his choices as he made them, saying it was about the terms of the arrangement.
He thought about what that meant and whether it meant anything.
He thought that it meant something. He wasn't sure exactly what. He set it aside for later.
He sent a message to Reese: The vaccine candidate works. Georgetown confirmed. CDC is scaling production. The acute cases will stop progressing.
Reese's response came back in forty seconds.
It was one word: Good.
David put the phone in his pocket.
"We're here," Root said.
She parked at the curb outside the CDC's emergency coordination center — a building that had taken on the specific character of a facility running at maximum operational capacity, the foot traffic and the lights and the communication equipment visible through the lobby windows.
David got out.
He carried the sequence data on his phone.
He walked in.
End of Chapter 159
[Chapter Rewards]
500 Power Stones unlock 1 chapter
10 Reviews unlock 1 chapter
Hope you enjoyed the chapter.
20+chapters ahead on P1treon Soulforger